Cannabidiol Reduces Nicotine Withdrawal Severity and State Anxiety During an Acute E-cigarette Abstinence Period: A Novel, Open-Label Study
- 1 August 2024
- journal article
- research article
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 9 (4) , 996-1005
Abstract
Introduction: Despite efforts to curb nicotine use, 8.1 million adults in the United States use e-cigarettes. Notably, the majority of nicotine-containing e-cigarette users report wanting to quit in the near future, yet there is a dearth of research surrounding intervention efforts. Cannabidiol (CBD) has potential to facilitate e-cigarette quit attempts by decreasing withdrawal symptom intensity and anxiety during nicotine e-cigarette abstinence. Methods: This study employed an open-label, crossover design (n=20) to test the hypothesis that among daily nicotine-containing e-cigarette users, oral administration of 320 mg CBD would reduce self-reported nicotine withdrawal severity and state anxiety following a 4-h e-cigarette abstinence period compared to withdrawal and anxiety reported after abstinence in the absence of CBD. Results: After controlling for participants' positive CBD expectancies, results were consistent with hypotheses, suggesting CBD reduced both nicotine withdrawal symptom severity and state anxiety during e-cigarette abstinence. Conclusion: These preliminary findings suggest testing the impact of CBD on e-cigarette cessation attempts is warranted.Keywords
This publication has 36 references indexed in Scilit:
- Evaluation of Electronic Cigarette Use (Vaping) Topography and Estimation of Liquid Consumption: Implications for Research Protocol Standards Definition and for Public Health Authorities’ RegulationInternational Journal of Environmental Research and Public Health, 2013
- Characteristics Associated With Awareness, Perceptions, and Use of Electronic Nicotine Delivery Systems Among Young US Midwestern AdultsAmerican Journal of Public Health, 2013
- Panic Attack History and Anxiety Sensitivity in Relation to Cognitive-Based Smoking Processes Among Treatment-Seeking Daily SmokersNicotine & Tobacco Research, 2012
- Phytocannabinoids as novel therapeutic agents in CNS disordersPharmacology & Therapeutics, 2012
- A Primer on Using Multilevel Models in Clinical and Experimental Psychopathology ResearchJournal of Experimental Psychopathology, 2011
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia PatientsNeuropsychopharmacology, 2011
- Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatmentAddiction, 2010
- Varenicline Improves Mood and Cognition During Smoking AbstinenceBiological Psychiatry, 2009
- Cigarette Smoking and Panic PsychopathologyCurrent Directions in Psychological Science, 2005
- Signs and Symptoms of Tobacco WithdrawalArchives of General Psychiatry, 1986